Site Members can sign up for company wide alerts
Investigation Overview
After Quest Diagnostics agreed to pay $241 million to settle a lawsuit that alleged the Company overcharged California's Medicaid program an investigation on behalf of on behalf of investors in shares of Quest Diagnostics Incorporated (NYSE:DGX) over possible breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Inc. was announced. The investigation by a ...
You must register (for free) or login to view the entire investigation.